Human flavin containing monooxygenase 3 is a drug-metabolizing enzyme involved in the oxidation of many drugs, chemicals and xenobiotics. It is predominantly expressed in the liver where its substrates, generally soft nucleophiles are transformed into more polar metabolites. The enzyme is attached to the smooth endoplasmic reticulum membrane, where its reduced flavin group binds molecular oxygen and readily performs nucleophilic attack on the substrates. To date the structure of hFMO3 has not been solved due to difficulties in the crystallization of microsomal, membrane-bound proteins. In the present study a molecular model of hFMO3 is constructed, exploited by in silico molecular dynamics experiments to identify the membrane anchor and used for the rational design of a soluble truncated hFMO3 enzyme.

Molecular modelling and protein engineering of a C-terminally truncated human flavin-containing monooxygenase 3

CATUCCI, GIANLUCA;SADEGHI, JILA;GILARDI, Gianfranco
2011-01-01

Abstract

Human flavin containing monooxygenase 3 is a drug-metabolizing enzyme involved in the oxidation of many drugs, chemicals and xenobiotics. It is predominantly expressed in the liver where its substrates, generally soft nucleophiles are transformed into more polar metabolites. The enzyme is attached to the smooth endoplasmic reticulum membrane, where its reduced flavin group binds molecular oxygen and readily performs nucleophilic attack on the substrates. To date the structure of hFMO3 has not been solved due to difficulties in the crystallization of microsomal, membrane-bound proteins. In the present study a molecular model of hFMO3 is constructed, exploited by in silico molecular dynamics experiments to identify the membrane anchor and used for the rational design of a soluble truncated hFMO3 enzyme.
2011
17th international conference on cytochrome P450: Biochemistry, Biophysics and Structure
Manchester
26-30 June 2011
17th international conference on cytochrome P450: Biochemistry, Biophysics and Structure
Andrew Munro
17
51
55
9788875876166
http://www.medimond.com/proceedings/detail.asp?id=20110626
human Phase I drug metabolising enzyme; flavin containing monoxygenase; molecular modelling; protein engineering
G. Catucci; S.J. Sadeghi; G. Gilardi
File in questo prodotto:
File Dimensione Formato  
N626C0106.doc

Accesso riservato

Tipo di file: PREPRINT (PRIMA BOZZA)
Dimensione 54.5 kB
Formato Microsoft Word
54.5 kB Microsoft Word   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2318/130321
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact